Jan
20
Sun
Online 8-Hour MAT Waiver Course @ Online
Jan 20 @ 12:00 am – 12:00 am

PCSS has developed a new 8-hour MAT waiver course that’s entirely online. No more looking for local trainings. No more traveling out of town or even out of state. We know you’re busy, so we’ve made it easy for you to get the training you need to prescribe buprenorphine to your patients with opioid use disorder.

Target Audience: Physicians who wish to apply for a waiver to prescribe buprenorphine.

Educational Objectives: At the conclusion of this activity, learners should be able to:

  • Review addiction identification and evidence-based treatments.
  • Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients.
  • Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient.
  • Explain the process of buprenorphine induction as well as stabilization and maintenance.
  • Discuss other approved antagonist and agonist medications to treat OUD.
  • Discuss basic office protocols including medical record documentation and confidentially.
  • Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD.
  • Apply for a MAT Waiver Training Certificate to begin treating patients with OUD.

Fee: No cost

Accreditation Statement: The American Academy of Addiction Psychiatry (AAAP) is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement: American Academy of Addiction Psychiatry (AAAP) designates this enduring material for a maximum of 8 (eight) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Jan
27
Sun
Online 8-Hour MAT Waiver Course @ Online
Jan 27 @ 12:00 am – 12:00 am

PCSS has developed a new 8-hour MAT waiver course that’s entirely online. No more looking for local trainings. No more traveling out of town or even out of state. We know you’re busy, so we’ve made it easy for you to get the training you need to prescribe buprenorphine to your patients with opioid use disorder.

Target Audience: Physicians who wish to apply for a waiver to prescribe buprenorphine.

Educational Objectives: At the conclusion of this activity, learners should be able to:

  • Review addiction identification and evidence-based treatments.
  • Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients.
  • Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient.
  • Explain the process of buprenorphine induction as well as stabilization and maintenance.
  • Discuss other approved antagonist and agonist medications to treat OUD.
  • Discuss basic office protocols including medical record documentation and confidentially.
  • Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD.
  • Apply for a MAT Waiver Training Certificate to begin treating patients with OUD.

Fee: No cost

Accreditation Statement: The American Academy of Addiction Psychiatry (AAAP) is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement: American Academy of Addiction Psychiatry (AAAP) designates this enduring material for a maximum of 8 (eight) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Feb
3
Sun
Online 8-Hour MAT Waiver Course @ Online
Feb 3 @ 12:00 am – 12:00 am

PCSS has developed a new 8-hour MAT waiver course that’s entirely online. No more looking for local trainings. No more traveling out of town or even out of state. We know you’re busy, so we’ve made it easy for you to get the training you need to prescribe buprenorphine to your patients with opioid use disorder.

Target Audience: Physicians who wish to apply for a waiver to prescribe buprenorphine.

Educational Objectives: At the conclusion of this activity, learners should be able to:

  • Review addiction identification and evidence-based treatments.
  • Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients.
  • Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient.
  • Explain the process of buprenorphine induction as well as stabilization and maintenance.
  • Discuss other approved antagonist and agonist medications to treat OUD.
  • Discuss basic office protocols including medical record documentation and confidentially.
  • Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD.
  • Apply for a MAT Waiver Training Certificate to begin treating patients with OUD.

Fee: No cost

Accreditation Statement: The American Academy of Addiction Psychiatry (AAAP) is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement: American Academy of Addiction Psychiatry (AAAP) designates this enduring material for a maximum of 8 (eight) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Feb
10
Sun
Online 8-Hour MAT Waiver Course @ Online
Feb 10 @ 12:00 am – 12:00 am

PCSS has developed a new 8-hour MAT waiver course that’s entirely online. No more looking for local trainings. No more traveling out of town or even out of state. We know you’re busy, so we’ve made it easy for you to get the training you need to prescribe buprenorphine to your patients with opioid use disorder.

Target Audience: Physicians who wish to apply for a waiver to prescribe buprenorphine.

Educational Objectives: At the conclusion of this activity, learners should be able to:

  • Review addiction identification and evidence-based treatments.
  • Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients.
  • Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient.
  • Explain the process of buprenorphine induction as well as stabilization and maintenance.
  • Discuss other approved antagonist and agonist medications to treat OUD.
  • Discuss basic office protocols including medical record documentation and confidentially.
  • Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD.
  • Apply for a MAT Waiver Training Certificate to begin treating patients with OUD.

Fee: No cost

Accreditation Statement: The American Academy of Addiction Psychiatry (AAAP) is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement: American Academy of Addiction Psychiatry (AAAP) designates this enduring material for a maximum of 8 (eight) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Feb
17
Sun
Online 8-Hour MAT Waiver Course @ Online
Feb 17 @ 12:00 am – 12:00 am

PCSS has developed a new 8-hour MAT waiver course that’s entirely online. No more looking for local trainings. No more traveling out of town or even out of state. We know you’re busy, so we’ve made it easy for you to get the training you need to prescribe buprenorphine to your patients with opioid use disorder.

Target Audience: Physicians who wish to apply for a waiver to prescribe buprenorphine.

Educational Objectives: At the conclusion of this activity, learners should be able to:

  • Review addiction identification and evidence-based treatments.
  • Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients.
  • Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient.
  • Explain the process of buprenorphine induction as well as stabilization and maintenance.
  • Discuss other approved antagonist and agonist medications to treat OUD.
  • Discuss basic office protocols including medical record documentation and confidentially.
  • Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD.
  • Apply for a MAT Waiver Training Certificate to begin treating patients with OUD.

Fee: No cost

Accreditation Statement: The American Academy of Addiction Psychiatry (AAAP) is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement: American Academy of Addiction Psychiatry (AAAP) designates this enduring material for a maximum of 8 (eight) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Feb
24
Sun
Online 8-Hour MAT Waiver Course @ Online
Feb 24 @ 12:00 am – 12:00 am

PCSS has developed a new 8-hour MAT waiver course that’s entirely online. No more looking for local trainings. No more traveling out of town or even out of state. We know you’re busy, so we’ve made it easy for you to get the training you need to prescribe buprenorphine to your patients with opioid use disorder.

Target Audience: Physicians who wish to apply for a waiver to prescribe buprenorphine.

Educational Objectives: At the conclusion of this activity, learners should be able to:

  • Review addiction identification and evidence-based treatments.
  • Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients.
  • Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient.
  • Explain the process of buprenorphine induction as well as stabilization and maintenance.
  • Discuss other approved antagonist and agonist medications to treat OUD.
  • Discuss basic office protocols including medical record documentation and confidentially.
  • Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD.
  • Apply for a MAT Waiver Training Certificate to begin treating patients with OUD.

Fee: No cost

Accreditation Statement: The American Academy of Addiction Psychiatry (AAAP) is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement: American Academy of Addiction Psychiatry (AAAP) designates this enduring material for a maximum of 8 (eight) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Mar
3
Sun
Online 8-Hour MAT Waiver Course @ Online
Mar 3 @ 12:00 am – 12:00 am

PCSS has developed a new 8-hour MAT waiver course that’s entirely online. No more looking for local trainings. No more traveling out of town or even out of state. We know you’re busy, so we’ve made it easy for you to get the training you need to prescribe buprenorphine to your patients with opioid use disorder.

Target Audience: Physicians who wish to apply for a waiver to prescribe buprenorphine.

Educational Objectives: At the conclusion of this activity, learners should be able to:

  • Review addiction identification and evidence-based treatments.
  • Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients.
  • Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient.
  • Explain the process of buprenorphine induction as well as stabilization and maintenance.
  • Discuss other approved antagonist and agonist medications to treat OUD.
  • Discuss basic office protocols including medical record documentation and confidentially.
  • Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD.
  • Apply for a MAT Waiver Training Certificate to begin treating patients with OUD.

Fee: No cost

Accreditation Statement: The American Academy of Addiction Psychiatry (AAAP) is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement: American Academy of Addiction Psychiatry (AAAP) designates this enduring material for a maximum of 8 (eight) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Mar
10
Sun
Online 8-Hour MAT Waiver Course @ Online
Mar 10 @ 12:00 am – 12:00 am

PCSS has developed a new 8-hour MAT waiver course that’s entirely online. No more looking for local trainings. No more traveling out of town or even out of state. We know you’re busy, so we’ve made it easy for you to get the training you need to prescribe buprenorphine to your patients with opioid use disorder.

Target Audience: Physicians who wish to apply for a waiver to prescribe buprenorphine.

Educational Objectives: At the conclusion of this activity, learners should be able to:

  • Review addiction identification and evidence-based treatments.
  • Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients.
  • Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient.
  • Explain the process of buprenorphine induction as well as stabilization and maintenance.
  • Discuss other approved antagonist and agonist medications to treat OUD.
  • Discuss basic office protocols including medical record documentation and confidentially.
  • Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD.
  • Apply for a MAT Waiver Training Certificate to begin treating patients with OUD.

Fee: No cost

Accreditation Statement: The American Academy of Addiction Psychiatry (AAAP) is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement: American Academy of Addiction Psychiatry (AAAP) designates this enduring material for a maximum of 8 (eight) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Mar
17
Sun
Online 8-Hour MAT Waiver Course @ Online
Mar 17 @ 12:00 am – 12:00 am

PCSS has developed a new 8-hour MAT waiver course that’s entirely online. No more looking for local trainings. No more traveling out of town or even out of state. We know you’re busy, so we’ve made it easy for you to get the training you need to prescribe buprenorphine to your patients with opioid use disorder.

Target Audience: Physicians who wish to apply for a waiver to prescribe buprenorphine.

Educational Objectives: At the conclusion of this activity, learners should be able to:

  • Review addiction identification and evidence-based treatments.
  • Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients.
  • Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient.
  • Explain the process of buprenorphine induction as well as stabilization and maintenance.
  • Discuss other approved antagonist and agonist medications to treat OUD.
  • Discuss basic office protocols including medical record documentation and confidentially.
  • Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD.
  • Apply for a MAT Waiver Training Certificate to begin treating patients with OUD.

Fee: No cost

Accreditation Statement: The American Academy of Addiction Psychiatry (AAAP) is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement: American Academy of Addiction Psychiatry (AAAP) designates this enduring material for a maximum of 8 (eight) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Mar
24
Sun
Online 8-Hour MAT Waiver Course @ Online
Mar 24 @ 12:00 am – 12:00 am

PCSS has developed a new 8-hour MAT waiver course that’s entirely online. No more looking for local trainings. No more traveling out of town or even out of state. We know you’re busy, so we’ve made it easy for you to get the training you need to prescribe buprenorphine to your patients with opioid use disorder.

Target Audience: Physicians who wish to apply for a waiver to prescribe buprenorphine.

Educational Objectives: At the conclusion of this activity, learners should be able to:

  • Review addiction identification and evidence-based treatments.
  • Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients.
  • Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient.
  • Explain the process of buprenorphine induction as well as stabilization and maintenance.
  • Discuss other approved antagonist and agonist medications to treat OUD.
  • Discuss basic office protocols including medical record documentation and confidentially.
  • Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD.
  • Apply for a MAT Waiver Training Certificate to begin treating patients with OUD.

Fee: No cost

Accreditation Statement: The American Academy of Addiction Psychiatry (AAAP) is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement: American Academy of Addiction Psychiatry (AAAP) designates this enduring material for a maximum of 8 (eight) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.